TELA Bio (TELA) Long-Term Deferred Tax (2019 - 2025)
TELA Bio (TELA) posted quarterly Long-Term Deferred Tax of $62000.0 for Q3 2025, down 3.12% quarter-over-quarter from $64000.0 in Q2 2025.
TELA Bio (TELA) Long-Term Deferred Tax (2019 - 2025) Analysis & Trends
TELA Bio's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $62000.0 for Q3 2025.
- In Q3 2025, Long-Term Deferred Tax changed N/A year-over-year to $62000.0; the TTM figure through Sep 2025 stood at $62000.0 (changed N/A YoY), while the FY2024 annual figure was $140000.0, changed N/A from the prior year.
- Long-Term Deferred Tax for Q3 2025 stood at $62000.0, down from $64000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $140000.0 in Q4 2024, with the low at $62000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | TELA Bio | 35.91 Mn | 5.49 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 92,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2019 | 1.73 Mn |